The purpose of this study was to compare tear physiology characteristics of chronic GVHD (cGVHD)-associated dry eye to dry eye caused by Sjogren's syndrome (SS), a extreme form of aqueous-deficient dry eye, and meibomian gland dysfunction (MGD), the major cause of evaporative dry eye. Tear turnover rate, evaporation and osmolarity along with meibomian gland dropout and lipid layer interferometric patterns were assessed in the right eyes of 12 patients with dry eye associated with cGVHD, 12 age-matched patients with SS and 12 age-sex matched subjects with MGD. In cGVHD, the decrease in tear turnover rate was similar (P ¼ 0.33), but the number of non-functioning meibomian glands was significantly higher (Po0.01) than in SS. Tear evaporation rate in cGVHD dry eye was found to be similar to that in MGD (P ¼ 0.36) and significantly higher than in SS (Po0.01). The lipid layer was most unstable in cGVHD compared with other groups. There was no variation in tear volume across all groups. Although statistical significance was not detected, the mean tear osmolarity (333.51± 14.67mOsm/L) was highest in cGVHD. Major aspects of tear physiology were severely impaired in cGVHDassociated dry eye.
Introduction
Dry eye is a primary ocular complication of chronic GVHD (cGVHD), with up to 62.5% of cGVHD sufferers shown to have developed the condition. [1] [2] [3] [4] The pathological effects of cGVHD on the tear film are known to be distinct from other biological causes of dry eye. 5 However, little information is available on the occurrence, clinical manifestation and severity of dry eye in cGVHD. A number of studies have shown that there are detrimental changes observed by a range of clinical tear and ocular surface function tests in cGVHD. 1, [6] [7] [8] The clinical parameters form a complex nexus, 9 which is difficult to untangle for the purpose of extracting useful information on the occurrence and overall pattern of dry eye. Furthermore, some of these functional changes (epithelial erosions 10 and corneal vascularisation 11 ) occur in diseases other than dry eye, making it difficult to ascertain whether the changes are because of that condition. Evaluating different aspects of tear physiology would provide a better understanding of the pattern and severity of the tear film disorder in cGVHD.
Tear physiology is a complex process that regulates the supply of various components of the tears to the ocular surface from the major and accessory lacrimal glands, meibomian gland and goblet cells, spread of the tears over the ocular surface, and loss through evaporation and drainage. These parameters can be assessed with a battery of tests measuring tear turnover and evaporation rate, lipid layer structure and meibomian gland efficacy. Tear osmolarity, as it is the result of the changes in tear dynamics, is considered to be the end-point of tear physiology. 12 As therapeutic products for dry eye targetspecific properties of tear physiology, 13 determining tear physiology changes in cGVHD-related dry eye would help in devising suitable treatment strategies.
There are only two published studies on cGVHDassociated dry eye that have included some measurements of tear physiology in their battery of tests. One study 7 evaluated spread of the lipid layer with an interferometer and a more recent one measured tear evaporation. 14 These studies offer an initial foray into these important aspects of tear physiology. However, for the purpose of acquiring crucial information of tear deficiency, it is critical to evaluate other aspects of tear physiology. This is an aspect, which might be expected to be affected in cGVHD.
In this study, to identify the pattern and severity of dry eye in cGVHD, we compared the tear physiological characteristics of cGVHD-associated dry eye to those in dry eye due to Sjogren's syndrome (SS), a severe cause of aqueous-deficiency dry eye, and those of meibomian gland dysfunction (MGD), the major primary cause of evaporative dry eye.
Materials and methods
This study was approved by Glasgow Caledonian University ethics committee and informed consent was obtained from all participants before their inclusion in the study.
For the purpose of this study, cGVHD was defined according to the criteria set by National Institute of Health. 15 The cGVHD patients with a clinical diagnosis of dry eye, were referred to the Tear Physiology Unit at Glasgow Caledonian University from Gartnavel Royal Hospital for their dry eye assessment between 2004 and 2008, were enroled in the study. These patients underwent standard conditioning and immunosuppressive therapy depending on severity and prognosis, and no modifications were made to their treatment regimen for the purpose of this study.
The cGVHD patients were compared with equal numbers of the randomly selected patients attending the Tear Physiology Unit with a primary clinical diagnosis of SS or MGD. Patients with MGD did not have other diseases that could have caused aqueous tear deficiency. Clinical diagnosis of dry eye was established by the referring ophthalmologist on the basis of symptoms, patient history, clinical observations, Schirmer I test, tear break-up time and autoantibody tests (antinuclear antibody screen followed up by anti-Rho or anti-La as necessary in the case of SS). All patients had positive-dry eye symptoms. Patients in the cGVHD group were agematched with those in the SS group and were age-sex matched to within ± 3 years of the MGD group. SS group could not be sex-matched to cGVHD as there were not enough male SS referrals.
Patients being treated with tear supplementation were instructed not to use any ocular lubricants for 48 h before tear evaluation. Laboratory tests were conducted on the right eye of all subjects to measure the turnover rate, evaporation and osmolarity of their tears. Dynamic interferometric pattern of the lipid layer and meibomian gland dropout were also assessed. Tear turnover rate was measured with a fluorophotometer 16 (Fluorotron Master, Coherent Radiation Inc., Santa Clara, CA, USA) to monitor the decay of fluorescein from the ocular surface over a 20 min period. A modified dermatological evaporimeter 17 (Servomed, Varberg, Sweden) was used to measure evaporative loss of the tears from the ocular surface. Approximately 1 mL of tears was collected from the lower tear meniscus with a flame-drawn microcapillary tube and the osmolarity of the sample collected was measured with a nanoliter osmometer system 18 (Clifton Technical Physics, Hartford, NY, USA). 19 A custom designed video interferometer 19 evaluated the interferometric pattern of the lipid layer. The meibomian glands were viewed directly by transillumination 18 to evaluate 'drop-out'.
Statistical analysis
The results obtained for individual measurements of tear quality, evaporation, turnover, volume and osmolarity and meibomian gland dropout were analysed by comparisons of means with Mann-Whitney U-test and Kruskal-Wallis tests as the data were not normally distributed. Results for individual tear parameters were combinated by discriminant canonical analysis to identify the differential proportional contribution of the different aspects of tear physiology in cGVHD, SS and MGD.
Results
A total of 36 subjects were recruited for the study; 12 patients with dry eye associated with cGVHD (9 males and 3 females, average age 51.3±13.1 years), 12 agematched patients with SS (2 males and 10 females, average age 52.4 ± 11.8 years) and 12 age and sex-matched patients with MGD (9 males and 3 females, average age 51.6±13.8 years). The mean and s.d. of the means of values obtained in assessments of these groups are shown in Table 1 . Tear turnover rate for cGVHD-associated dry eye was found to be similar to SS (P ¼ 0.33) and lower than MGD (Po0.01) (Figure 1 ). Tear evaporation in cGVHD was at similar levels to that of MGD (P ¼ 0.36), but was significantly higher than SS (Po0.01) (Figure 2 ). Differences in evaporation rates were consistent with the level of meibomian gland dropout and lipid layer observations made with the interferometer. Meibomian gland dropout rates in cGVHD were significantly higher than those associated with dry eye in SS (P ¼ 0.04) and at similar levels to those of MGD (P ¼ 0.43). An unstable lipid layer was observed in B70% of patients with cGVHD-associated dry eye and MGD, compared with 50% of patients with SS ( Figure 3 ). There was no difference in the total volume of tears on the ocular surface between all groups.
Tear osmolarity in cGVHD was not statistically different from other groups although the mean value was higher (Table 1) . However, the data trend suggests that the small Table 1 Results of tear physiology and gland assessments in dry eye associated with cGVHD, SS and MGD (n ¼ 12 in each group) (Figure 4 ). Discriminant function analysis was used to discriminate cGVHD from SS and MGD, and showed that the standardised proportional contribution of tear turnover rate, gland dropout scores and tear evaporation were À0.71, 0.69 and 0.64. When discrimination was attempted between cGVHD and SS, tear evaporation was the only parameter that showed any distinction between these two groups. Similarly, a discriminant function for dry eye caused by cGVHD against that with MGD yielded proportional contributions of tear turnover rate and gland dropout with standardised coefficients of 0.79 and À0.75. Overall, the interpretation from the discriminant function analysis is that all aspects of tear physiology are severely affected in cGVHD, unlike with SS and MGD of dry eye where a predominant effect is seen for individual aspects of tear physiology.
Discussion
In the current study, tear turnover in cGVHD-associated dry eye was found to be at similar levels to that of SS, suggesting that the lacrimal gland functionality is severely compromised in cGVHD. Unquantifiable reflex secretion following the insertion of Schirmer strips makes it difficult to assess the agreement of our findings with previous reports of Schirmer test results in cGVHD. The general trend observed with cGVHD dry eye patients was of low Schirmer test values, 2, 7, 8, 14, 20, 21 supporting the impairment of tear production in cGVHD-associated dry eye. A histological study has shown that there is a predominant infiltration of T-cells into the periductal area, an increase in the number of stromal fibroblasts and excessive fibrosis in Although no statistically significant differences were found, the data indicates that the tear osmolarity values for cGVHD-associated dry eye are higher than that for the other groups.
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No of subjects The spread of the data indicates that the tear turnover rates for cGVHDassociated dry eye are statistically lower than that for MGD (Po0.01) and at equivalent levels of SS (P ¼ 0.33).
Tear physiology in cGVHD S Khanal and A Tomlinson the extracellular matrix of the lacrimal glands in cGVHDassociated dry eye. 22 The occurrence of stromal fibrosis in cGVHD suggests that the pathogenesis of the lacrimal glands in cGVHD is different to that in SS. 23 Despite these differences in pathological processes, the current study shows that the end result in terms of tear production is similar in dry eye because of cGVHD and SS.
In addition to deficient tear production, tear evaporation rate and meibomian gland functions also appear to be significantly compromised in cGVHD. This is in agreement with the inferences drawn in previous studies, 7, 8, 14 although there are differences in the instrumentation used in the different studies. It is noteworthy that Wang et al.
14 did not find a statistically detectable difference between tear evaporation rates of BM transplant recipients with and without cGVHD. This raises the possibility that lipid disorders could occur even in those BM transplant recipients who do not develop cGVHD. Considering the oxidising effect of radiotherapy on other lipids within the body, 24 the tear lipids, if affected similarly, would release radical oxygen species on the ocular surface, thereby destabilising the lipid layer and subsequently disrupting the balance of tear dynamics. 25 All BM transplant recipients should therefore be monitored for dry eye, irrespective of the occurrence of cGVHD.
Interestingly, the damage to the lipid layer and the meibomian glands found in cGVHD-associated dry eye in the present study was considerably more than in SS and similar to the levels of lipid deficiency seen in MGD, the primary cause of lipid disorders. Lipid synthesis processes of the meibomian glands are known to be affected by hormonal (mostly androgen), vascular and neuronal influences. 26, 27 Although there is no evidence of neuronal and vascular impairment of the meibomian and other accessory lipid producing glands in cGVHD, variation in androgen levels can have an influence on lipid synthesis by meibomian glands. A 95% incidence of ovarian failure in female cGVHD sufferers and 47% incidence of spermatogenesis failure in their male counterparts indicates the potential for a significant androgen deficiency, 27 which could cause a reduced functionality of the meibomian glands.
The cumulative outcome of the detrimental effects on tear turn over, evaporation and the meibomian glands due to the multifaceted pathological processes in cGVHD would lead to a radically compromised functionality of the tear film and a severe form of dry eye with both aqueous and lipid layers highly compromised. Severity of dry eye in cGVHD is confirmed by the discriminant functions derived in this study and the highest tear osmolarity measurements observed for this group of patients. Tear hyperosmolarity is known to trigger a cascade of inflammatory events on the ocular surface leading to cell death by apoptosis, a loss of goblet cells and disturbance of mucin expression. 28 Ocular surface manifestations reported in cGVHD including corneal ulceration 29 and conjunctival abnormalities 30 are possibly dry eye sequelae. It is imperative to restore the balance in tear dynamics in cGVHD-related dry eye to prevent unwarranted ocular surface morbidity and a subsequent loss of visual function.
Moderate and severe forms of cGVHD dry eye lead to significant impairment of health-related quality of life. 31, 32 Because of the involvement of numerous body tissues in the whole disease process, it is difficult to quantify the relative contribution of dry eye in the compromised quality of life of cGVHD patients. The ongoing debilitating symptoms of severe dry eye, however, would undoubtedly limit the socio-economic functional abilities 33 of a cGVHD dry eye sufferer.
In summary, cGVHD can cause considerable detrimental changes in tear production and evaporation and meibomian gland function, with a corresponding severe hyperosmolarity of the tears. This can lead to severe disruption in the balance of tear dynamics and be a cause of cellular damage on the ocular surface. The effects on the lacrimal and meibomian glands in cGVHD lead to a severe form of mixed aqueous deficiency and evaporative dry eye.
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